- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: abetimus sodium (LJP 394)
Total 26 results
-
La Jolla Pharmaceutical CompanyTerminatedLupus Erythematosus, Systemic | Lupus NephritisTaiwan, United States, Belarus, Serbia, Czech Republic, Philippines, Lebanon, India, Korea, Republic of, Argentina, Australia, Brazil, Bulgaria, Georgia, Germany, Hong Kong, Hungary, Indonesia, Italy, Malaysia, Mexico, Poland, Portugal and more
-
La Jolla Pharmaceutical CompanyWithdrawn
-
La Jolla Pharmaceutical CompanyCompletedAutoimmune Diseases | Systemic Lupus Erythematosus | Lupus Nephritis | Immunologic Diseases | Lupus GlomerulonephritisUnited States, Austria, Canada, France, Germany, Italy, Mexico, Spain, Sweden, United Kingdom
-
Sen-Jam PharmaceuticalCompleted
-
La Jolla Pharmaceutical CompanyApproved for marketingSepsis | Vasodilatory Shock | Distributive Shock | High Output Shock | Catecholamine Resistant Hypotension (CRH)
-
National Institute of Allergy and Infectious Diseases...Gritstone bio, Inc.Completed
-
La Jolla Pharmaceutical CompanyCompletedSepsis | Catecholamine-resistant Hypotension (CRH) | Distributive Shock | High Output ShockUnited States, Canada, Belgium, Australia, United Kingdom, Finland, New Zealand, France, Switzerland, Germany
-
University of WashingtonFred Hutchinson Cancer CenterWithdrawn
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCTerminated
-
La Jolla Pharmaceutical CompanyRecruitingSeptic Shock | Catecholamine-resistant Hypotension (CRH) | Distributive Shock | High Output ShockBelgium, Lithuania
-
Lykos TherapeuticsCompletedPosttraumatic Stress DisorderUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin LymphomaUnited States
-
Medical University of ViennaCompleted
-
U.S. Army Medical Research and Development CommandMilitary Infectious Diseases Research Program (MIDRP)Completed
-
King Abdulaziz UniversityCompletedCOVID-19 | Covid19 | SARS-CoV-2 | Coronavirus | Saliva | Viral Load | Polymerase Chain Reaction | MouthwashesSaudi Arabia
-
Pulmotect, Inc.WCCT GlobalCompleted
-
University of BeykentCompleted
-
University of PittsburghEli Lilly and Company; Genentech, Inc.Completed
-
VA Office of Research and DevelopmentUniversity of California, San FranciscoRecruiting
-
Baskent UniversityCompletedHip Fracture | Chronic Renal FailureTurkey
-
Children's Oncology GroupNot yet recruitingRecurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Juvenile Myelomonocytic Leukemia
-
Children's Oncology GroupRecruitingRecurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Refractory Acute Leukemia of Ambiguous Lineage | Recurrent Acute Leukemia of Ambiguous Lineage | Recurrent Acute Myeloid Leukemia... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States
-
National Cancer Institute (NCI)Active, not recruitingAdult T Acute Lymphoblastic Leukemia | Childhood T Acute Lymphoblastic Leukemia | Ann Arbor Stage II Adult Lymphoblastic Lymphoma | Ann Arbor Stage II Childhood Lymphoblastic Lymphoma | Ann Arbor Stage III Adult Lymphoblastic Lymphoma | Ann Arbor Stage III Childhood Lymphoblastic Lymphoma | Ann... and other conditionsUnited States, Canada, Australia, New Zealand
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Puerto Rico, Israel